However, when Yki was overexpressed and dPGC1 was depleted in a Cyclin E heterozygous background, tumor size was dramatically reduced, indicating that reduced Cyclin E dosage specifically impairs tumor growth under these conditions (Fig 6M–6O). The gene discussed is CCNE1; the disease is neoplasm.